Algorics releases latest version of its acuity solution - a regulatory compliant risk management software platform for clinical trial monitoring, and announces new trading name to provide a single global identity
Houston, TX, USA, For Release: 5th August 2015. Algorics, a provider of clinical analytics solutions and software for the global life sciences industry, today announced the release of the latest version of its acuity solution - designed for use by pharma, biotech, CRO and academic organizations to drive regulatory compliant processes around management of risk. The acuity solution allows organizations to assess and capture the risk profile for a clinical trial and map risks to intelligent actions as part of the risk based monitoring paradigm.
Key features of the new release include out the box:
Implement cross-functional risk planning utilizing the acuity risk plan™ module:
Teams can collaborate in the cloud on identifying risks, determine mitigation strategies and related key risk indicators, and assign responsibilities in an integrated risk management plan aligned with industry and regulatory authority best practices.
Empower your central monitoring team utilizing the acuity insights™ module:
Leverage acuity’s integration engine to bring together multiple data streams, define real-time alerts and monitor signals in the data, and access the acuity insights library of over 150 data visualization templates.
Transform site monitoring utilizing the acuity profiles™module:
Take a detailed look at site and subject profiles that highlight where your site monitors should focus their time and effort.
New Trading Name: In conjunction with this release of acuity the company has also begun trading as Algorics (previously known as Algorithm) to provide a single global identity as the organization continues to grow in all markets.
Quote: Algorics Chief Commercial Officer Rob Nichols said “We are delighted to announce these major developments which support our rapid expansion. By continuing to invest heavily in product R&D, together with our belief that solutions should allow companies to manage risk across the lifespan of a clinical trial as well as around the monitoring of data, we are being rewarded with increased customer traction.”
About Algorics: Algorics brings together a team of highly experienced software and life sciences professionals, united behind a single goal: to provide innovative clinical analytics solutions and software to the global life sciences industry with consistent and reliable quality.
For more information about Algorics and acuity visit our new website: www.algorics.com or stay updated by following us on social media:
http://twitter.com/algorics
https://www.facebook.com/algorics
https://www.linkedin.com/company/algorics
PR Contact: Rob Nichols Algorics
Email: rob@algorics.com 5100 Westheimer Road,
Phone: +44 7720 891283 Suite 200, Houston, Texas -77056, USA
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.